In the group of critical COVID-19 patients, the only marker affected by hypertension was s-VCAM-1, with significantly higher values being observed at admission and at days 3–4 (P = 0.010 and P = 0.045 vs. normotensive, respectively) (Table 2). This evidence concerns the gene VCAM1 and hypertensive disorder.